TNF and juvenile idiopathic arthritis: Subsequently, a presentation at the American College of Rheumatology (ACR)/Associate Rheumatology Health Professional 2009 Annual Scientific Meeting reported that in 1,168 patients over 16,396 patient-years, no increased risk of anti-TNF therapy in JIA patients was found [44].